IL299918A - A screening method for diagnosing growth hormone deficiency in patients who are children using McMurlin - Google Patents

A screening method for diagnosing growth hormone deficiency in patients who are children using McMurlin

Info

Publication number
IL299918A
IL299918A IL299918A IL29991823A IL299918A IL 299918 A IL299918 A IL 299918A IL 299918 A IL299918 A IL 299918A IL 29991823 A IL29991823 A IL 29991823A IL 299918 A IL299918 A IL 299918A
Authority
IL
Israel
Prior art keywords
macimorelin
minutes
subject
growth hormone
blood samples
Prior art date
Application number
IL299918A
Other languages
English (en)
Hebrew (he)
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of IL299918A publication Critical patent/IL299918A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/61—Growth hormones [GH] (Somatotropin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL299918A 2020-07-22 2020-07-22 A screening method for diagnosing growth hormone deficiency in patients who are children using McMurlin IL299918A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2020/070691 WO2022017599A1 (fr) 2020-07-22 2020-07-22 Méthode de criblage permettant le diagnostic d'une déficience en hormone de croissance chez des patients pédiatriques à l'aide de la macimoréline

Publications (1)

Publication Number Publication Date
IL299918A true IL299918A (en) 2023-03-01

Family

ID=71784051

Family Applications (1)

Application Number Title Priority Date Filing Date
IL299918A IL299918A (en) 2020-07-22 2020-07-22 A screening method for diagnosing growth hormone deficiency in patients who are children using McMurlin

Country Status (12)

Country Link
EP (1) EP4185866A1 (fr)
JP (1) JP7767387B2 (fr)
KR (1) KR102635025B1 (fr)
CN (3) CN120294344A (fr)
AR (1) AR124626A1 (fr)
AU (1) AU2020460118B2 (fr)
CA (1) CA3185680A1 (fr)
IL (1) IL299918A (fr)
MX (1) MX2023000935A (fr)
PY (1) PY2157770A (fr)
TW (1) TW202219511A (fr)
WO (1) WO2022017599A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE370119T1 (de) 2000-06-13 2007-09-15 Zentaris Gmbh Wachstumhormonsekretionsförderer
GB0603295D0 (en) * 2006-02-18 2006-03-29 Ardana Bioscience Ltd Methods and kits
JP2016514132A (ja) * 2013-03-11 2016-05-19 アムニクス オペレーティング インコーポレイテッド ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
US10288629B1 (en) * 2017-12-19 2019-05-14 Aeterna Zentaris, Inc. Method of assessing growth hormone deficiency in humans by a macimorelin containing composition

Also Published As

Publication number Publication date
MX2023000935A (es) 2023-02-22
CN120294343A (zh) 2025-07-11
TW202219511A (zh) 2022-05-16
CA3185680A1 (fr) 2022-01-27
WO2022017599A1 (fr) 2022-01-27
NZ795810A (en) 2025-06-27
CN120294344A (zh) 2025-07-11
KR102635025B1 (ko) 2024-02-07
CN114258492A (zh) 2022-03-29
AU2020460118A1 (en) 2023-02-02
PY2157770A (es) 2022-03-30
AR124626A1 (es) 2023-04-19
KR20220015466A (ko) 2022-02-08
EP4185866A1 (fr) 2023-05-31
JP7767387B2 (ja) 2025-11-11
JP2023535000A (ja) 2023-08-15
AU2020460118B2 (en) 2024-11-07

Similar Documents

Publication Publication Date Title
NIEMAN et al. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome
Wolf et al. Effect of extradural analgesia on stress responses to abdominal surgery in infant
Orenstein Prone positioning in infant gastroesophageal reflux: is elevation of the head worth the trouble?
Arslanian et al. Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia
Desai et al. A survey of phenotypic features in juvenile polyposis.
O'hare et al. Sotalol as a hypotensive agent in pregnancy
Sahin et al. Upper cervical vertebrae movement during intubating laryngeal mask, fibreoptic and direct laryngoscopy: a video-fluoroscopic study
Ciccone et al. Endothelial and metabolic function interactions in overweight/obese children: the role of high-molecular weight adiponectin
Couriel et al. Long term pulmonary consequences of oesophageal atresia with tracheo‐oesophageal fistula
US20230338287A1 (en) Amlodipine formulations
CN116459250A (zh) 检测和治疗生长激素缺乏症
Di Rocco et al. Pituitary microadenomas in children
IL299918A (en) A screening method for diagnosing growth hormone deficiency in patients who are children using McMurlin
Efron et al. Effect of elevated plasma phenylalanine levels on other amino acids in phenylketonuric and normal subjects
Kirch et al. Dose‐dependence of the nifedipine‐digoxin interaction?
Oren et al. Ventilatory effects of almitrine bismesylate in congenital central hypoventilation syndrome
FIDLER et al. Excretion of oxprenolol and timolol in breast milk
McGuigan et al. Effect of parathyroidectomy on hypercalcemic hypersecretory peptic ulcer disease
Elliott et al. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels
IL275275B2 (en) Method for assessing growth hormone deficiency in humans using a preparation containing mesimorelin
Lye et al. Haemodynamic and neurohumoral responses in elderly patients with postural hypotension
Fixley et al. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline
Boiten et al. Isolated monoparesis is usually caused by superficial infarction
Goh et al. Head positioning for stroke blood flow augmentation assisting reperfusion therapies study
NZ795810B2 (en) A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin